Theranostics 2021; 11(14):7128-7129. doi:10.7150/thno.62534

Erratum

CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum

Wenzhi Shen1,2, Corresponding address, Xiaoyuan Zhang1,2, Jiaping Tang3, Zhixin Zhang4, Renle Du5, Dehong Luo6, Xiaoran Liu1, Yong Xia1, Yanping Li1, Shanshan Wang1, Siyuan Yan1, Wancai Yang1, Rong Xiang5, Na Luo3, Yunping Luo7, Jianjun Li2

1. Dept. of Pathology and Institute of Precision Medicine, Jining Medical University, Jining 272067, China.
2. Institute of Breast Research, Jining Medical University, Jining 272067, China.
3. Dept. of Anatomy and Histology, School of Medicine, Nankai University, Tianjin 300071, China.
4. Dept. of Gastrointestinal Surgery, Affiliated Hospital of Jining Medical University, Jining 272029, China.
5. Dept. of Immunology, School of Medicine, Nankai University, Tianjin 300071, China.
6. The First People's Hospital of Zunyi, Zunyi, 563002, China.
7. Dept. of Immunology, Institute of Basic Medical Science, Chinese Academy of Medical Science, School of Basic Medicine Peking Union Medical College, Beijing, 100005, China.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Shen W, Zhang X, Tang J, Zhang Z, Du R, Luo D, Liu X, Xia Y, Li Y, Wang S, Yan S, Yang W, Xiang R, Luo N, Luo Y, Li J. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum. Theranostics 2021; 11(14):7128-7129. doi:10.7150/thno.62534. Available from https://www.thno.org/v11p7128.htm

File import instruction

Corrected-article in Theranostics, Volume 11, 2297

 

In our article [1], there were misplaced images in Figure 7E and Figure 8D, respectively. The corrected version is provided here:

 Figure 7 

E. Immunohistochemistry staining of CCR2, p-AKT, p-GSK3β, β-catenin and OCT4 in each group tumors was performed. Representative images were shown. Scale bars: 50 μm.

Theranostics Image (Click on the image to enlarge.)
 Figure 8 

D. The representative luciferase images showing 231-luci tumors of each group on Day 12 (before XAV939 administration) and Day 60 (after XAV939 administration).

Theranostics Image (Click on the image to enlarge.)

The correction made in this erratum does not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that this error may have caused.

References

1. Shen WZ, Zhang XY, Tang JP, Zhang ZX, Du RL, Luo DH. et al. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis. Theranostics. 2021;11:2297-317 doi:10.7150/thno.51000

Author contact

Corresponding address Corresponding author: Wenzhi Shen, Dept. of Pathology and Institute of Precision Medicine & Institute of Breast Research, Jining Medical University, Jining 272067, China. E-mail: shenwenzhijnmc.edu.cn


Published 2021-5-15